Procurement Summary
Country : Germany
Summary : Conclusion of Non-Exclusive Discount Agreements According to § 130 a Paragraph 8 Sgb V for Drugs with the Active Ingredient Molsidomine (Tab)
Deadline : 10 Nov 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 84221584
Document Ref. No. : 346378-2023
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
§ 130a paragraph 8 SGB V enables the health insurance companies (KK) and pharmaceutical companies to conclude framework discount agreements for the drugs to be dispensed at the expense of the statutory KK. The GWQ is registered as a society for economy and quality at KK according to § 130a Abs. 8 S. 5 SGBV for their Ashareholder and customer checkouts. With regard to the relevant legal regulations for awarding public contracts, a regular process of active ingredient-related, formal award procedures takes place according to the regulations of Part 4 of the GWB by GWQ ServicePlus AG. untilWhen new drug discount agreements come into force, the GWQ would like to conclude drug discount agreements with all interested pharmaceutical companies. Contract start is 07/01/2023
Doc Title: Pharmaceutical products
Contract Type: Supplies
Document Type : Corrigendum/Additional information (Please refer tender document)
Reference Number : 2023/S 110-346378
Contract Type : Supplies
33600000 - Pharmaceutical products
Authority Type : Body governed by public law
Type of Procedure : Open procedure
Regulation : European Union
Bid Type : Submission for all lots
Doc Title : Pharmaceutical products
Dispatch Date : 2023-06-05
Publish Date : 2023-06-09
Submission Date : 2024-11-10
Documents
Tender Notice